General & Plastic Surgery Devices - Gambia

The General & Plastic Surgery Devices market market in Gambia is forecasted to achieve a revenue of US$193.20k in the year 2024.
Looking ahead, it is expected to exhibit an annual growth rate (CAGR 2024-2029) of 6.63%, leading to a market volume of US$266.40k by 2029.
When compared to other countries worldwide, the United States is projected to generate the highest revenue of US$9.84bn in 2024.
Gambia's General & Plastic Surgery Devices market is witnessing a surge in demand due to the increasing popularity of medical tourism in the country.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Gambia has been witnessing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the General & Plastic Surgery Devices market in Gambia have been influenced by global trends. Consumers are increasingly seeking minimally invasive procedures that offer quick recovery times and natural-looking results. This has led to a growing demand for devices such as laser systems, injectables, and implants. Additionally, there is a rising interest in cosmetic procedures among the younger population, driven by social media and the desire to enhance one's appearance. Trends in the market indicate a shift towards advanced technology and innovative solutions. The introduction of new surgical techniques and devices has improved the precision and effectiveness of procedures. For example, the use of 3D imaging technology has revolutionized the planning and execution of plastic surgeries, resulting in better outcomes for patients. Furthermore, the increasing popularity of non-surgical procedures, such as dermal fillers and Botox injections, has driven the demand for corresponding devices in the market. Local special circumstances in Gambia have also played a role in the development of the General & Plastic Surgery Devices market. The country has a growing middle class with disposable income, which has increased the affordability of cosmetic procedures. Additionally, Gambia is a popular medical tourism destination, attracting patients from neighboring countries who seek high-quality healthcare services at a lower cost. This has created a favorable environment for the growth of the General & Plastic Surgery Devices market in the country. Underlying macroeconomic factors have further contributed to the development of the market. Gambia has experienced stable economic growth in recent years, which has resulted in increased healthcare spending. The government's focus on improving healthcare infrastructure and services has also supported the growth of the General & Plastic Surgery Devices market. Furthermore, Gambia's strategic location as a gateway to West Africa has attracted investments from international healthcare companies, leading to the availability of a wide range of products in the market. In conclusion, the General & Plastic Surgery Devices market in Gambia is developing due to customer preferences for minimally invasive procedures, trends towards advanced technology, local special circumstances such as a growing middle class and medical tourism, and underlying macroeconomic factors including stable economic growth and government support for healthcare.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.